Ambagon Therapeutics
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $45M
Investors
- 8
About Ambagon Therapeutics
Ambagon Therapeutics Inc.Founded in 2020 and headquartered in San Carlos, US, Ambagon Therapeutics Inc. develops therapeutics aimed at traditionally undruggable proteins.Ambagon Therapeutics specializes in developing innovative therapeutics that target intrinsically disordered proteins, deemed undruggable. Their proprietary platform employs 14-3-3 molecular glue technology, allowing modulation of protein-protein interactions and expanding the druggable proteome for various diseases including cancers and neurodegenerative disorders.Ambagon Therapeutics generates revenue through strategic partnerships with biopharmaceutical companies that utilize its proprietary technology for drug development. The company typically enters collaborative agreements that include milestone payments and royalties, sharing research and development costs to create a viable financial structure.
Who invested in Ambagon Therapeutics
8 investors across 1 round
See all investors in Ambagon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 5, 2022
Amount
$45M
Investors
Questions about Ambagon Therapeutics
Who invested in Ambagon Therapeutics?
Ambagon Therapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ambagon Therapeutics raised?
Ambagon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ambagon Therapeutics last raise money?
Ambagon Therapeutics's most recent round on record is a Series A, in Jan 2022.
What does Ambagon Therapeutics do?
Ambagon Therapeutics is a biotechnology company.
Where is Ambagon Therapeutics headquartered?
Ambagon Therapeutics is headquartered in San Carlos, US.
Which VCs invest in companies like Ambagon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ambagon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ambagon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.